PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15921304-6	2005	On the basis of FIP1L1-PDGFRa fusion gene hypereosinophilic syndrome would be classified as a clonal disease and in the FIP1L1-PDGFRa positive cases the tyrosine kinase inhibitor imatinib mesylate (Glivec) would be effective.	Imatinib Mesylate	179-196	factor interacting with PAPOLA and CPSF1	Homo sapiens	120-126	
15921304-6	2005	On the basis of FIP1L1-PDGFRa fusion gene hypereosinophilic syndrome would be classified as a clonal disease and in the FIP1L1-PDGFRa positive cases the tyrosine kinase inhibitor imatinib mesylate (Glivec) would be effective.	Imatinib Mesylate	179-196	platelet derived growth factor receptor alpha	Homo sapiens	127-133